enow.com Web Search

  1. Ads

    related to: steglatro vs farxiga

Search results

  1. Results from the WOW.Com Content Network
  2. SGLT2 inhibitor - Wikipedia

    en.wikipedia.org/wiki/SGLT2_inhibitor

    It was approved for use in the United States under the brand name Farxiga in January 2014. [29] Empagliflozin, approved in the United States in August 2014, under the brand name Jardiance by Boehringer Ingelheim. [30] Of the gliflozins, empagliflozin and tofogliflozin have the highest specificity for SGLT2 inhibition. [1]

  3. A diabetes drug may help prevent dementia, new research shows

    www.aol.com/diabetes-drug-may-help-prevent...

    The first SGLT-2 inhibitor approved for use in the United States was dapagliflozin (Farxiga), in 2014. ... (Steglatro). Beyond their benefits for people with type 2 diabetes, ...

  4. Ertugliflozin - Wikipedia

    en.wikipedia.org/wiki/Ertugliflozin

    Ertugliflozin, sold under the brand name Steglatro, is a medication used for the treatment of type 2 diabetes. [ 3 ] [ 4 ] The most common side effects include fungal infections of the vagina and other infections of the female reproductive system.

  5. Dapagliflozin - Wikipedia

    en.wikipedia.org/wiki/Dapagliflozin

    Dapagliflozin, sold under the brand names Farxiga (US) and Forxiga (EU) among others, is a medication used to treat type 2 diabetes. [ 6 ] [ 7 ] [ 10 ] It is also used to treat adults with heart failure and chronic kidney disease .

  6. Merck's Steglatro Non-Inferior in Cardiovascular ... - AOL

    www.aol.com/news/mercks-steglatro-non-inferior...

    Merck's (MRK) type 2 diabetes drug, Steglatro, achieves primary endpoint of non-inferiority in major adverse CV events compared to placebo in a late-stage cardiovascular outcomes study.

  7. AOL Mail

    mail.aol.com

    Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!

  1. Ads

    related to: steglatro vs farxiga